Medicare Enrolled
Dr. Patrick Higgins, MD
Ophthalmology · Bloomfield, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Higgins from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Higgins?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Higgins
Dr. Patrick Higgins is an ophthalmology specialist in Bloomfield, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Higgins performed 28,202 Medicare services across 3,129 unique beneficiaries.
Between the years covered by Open Payments, Dr. Higgins received a total of $13,204 from 38 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Higgins is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in NJ
$13,204 industry payments
Medicare Practice Summary
Medicare Utilization ↗28,202
Medicare services
Top 2% in NJ for ophthalmology
3,129
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,484 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
19,983 | $29 | $60 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
1,632 | $34 | $131 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,420 | $102 | $356 |
| Injection, ranibizumab, 0.1 mg | 1,180 | $186 | $499 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,077 | $103 | $481 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
567 | $12 | $84 |
| Aflibercept eye injection (Eylea) | 565 | $694 | $1,393 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
375 | $120 | $200 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
222 | $19 | $85 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
218 | $77 | $248 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
178 | $120 | $326 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
116 | $1 | $3 |
| Fluorescein angiography of the eye An imaging test of the front part of the eye using a special camera after a dye is injected to visualize blood flow. |
90 | $118 | $380 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
86 | $10 | $20 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
85 | $1,145 | $3,851 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
78 | $66 | $447 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
70 | $112 | $298 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
62 | $30 | $208 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
55 | $114 | $426 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
34 | $41 | $140 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
26 | $37 | $148 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
20 | $433 | $1,200 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
19 | $54 | $150 |
| Removal of retinal membrane A surgical procedure to remove a membrane from the surface of the retina. |
17 | $932 | $2,600 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
14 | $37 | $154 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
13 | $553 | $2,058 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,204
Total received (2018-2024)
Avg $1,886/year across 7 years
Top 8% in NJ for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,402 (48.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,376 (48.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$426 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$839
2023
$647
2022
$898
2021
$137
2020
$567
2019
$2,933
2018
$7,182
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$134
Bausch & Lomb Americas Inc.
$114
Tarsus Pharmaceuticals, Inc.
$108
SUN PHARMACEUTICAL INDUSTRIES INC.
$107
ABBVIE INC.
$74
Alimera Sciences, Inc.
$61
Apellis Pharmaceuticals, Inc.
$61
Harrow Eye, LLC
$59
Ocular Therapeutix, Inc.
$36
Astellas Pharma US Inc
$34
Genentech USA, Inc.
$32
Heron Therapeutics, Inc.
$20
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$6,744
Roche TCRC, Inc.
$2,437
Genentech USA, Inc.
$461
Apellis Pharmaceuticals, Inc.
$357
Alimera Sciences, Inc.
$291
Sun Pharmaceutical Industries Inc.
$272
Allergan, Inc.
$211
NotalVision
$208
Alcon Vision LLC
$196
Coherus Biosciences Inc.
$195
RxSight Inc
$158
ABBVIE INC.
$150
Alcon Laboratories Inc
$150
Ocular Therapeutix, Inc.
$127
Bausch & Lomb Americas Inc.
$114
Tarsus Pharmaceuticals, Inc.
$108
Dompe US, Inc.
$108
SUN PHARMACEUTICAL INDUSTRIES INC.
$107
BIOTISSUE HOLDINGS, INC.
$101
Novartis Pharmaceuticals Corporation
$81
Mallinckrodt LLC
$78
Regeneron Pharmaceuticals, Inc.
$70
Allergan Inc.
$69
EyePoint Pharmaceuticals US, Inc.
$64
Astellas Pharma US Inc
$62
Harrow Eye, LLC
$59
Hoffmann-La Roche Limited
$38
Aerie Pharmaceuticals, Inc.
$29
Ethicon US, LLC
$24
Heron Therapeutics, Inc.
$20
Carl Zeiss Meditec AG
$19
Kala Pharmaceuticals, Inc.
$16
Eyevance Pharmaceuticals LLC
$16
Mallinckrodt Enterprises LLC
$14
Spark Therapeutics, Inc.
$13
ACELL, INC.
$13
Bausch & Lomb, a division of Bausch Health US, LLC
$13
Mallinckrodt Hospital Products Inc.
$13
Top 3 companies account for 73.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Cequa · Cimerli · DEXTENZA · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYSUVIS · Flarex · ForeseeHome · ILUVIEN · Iluvien · Izervay · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LUMIGAN · LUXTURNA · Lucentis · Non-Covered Product · None Specified · OXERVATE · OZURDEX · PROKERA · PROLENSA · Rhopressa · Syfovre · VABYSMO · VISTASEAL · Vabysmo · XDEMVY · YUTIQ · ZYNRELEF · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (48%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for ophthalmology in NJ.
Geographic Context
Ophthalmologists within 10 mi
1,270
Per 100K population
148.7
County median income
$76,712
Nearest hospital
HACKENSACK MERIDIAN MOUNTAINSIDE MEDICAL
1.7 mi
1.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Higgins is a mixed practice specialist, with above-average Medicare volume (top 2% in NJ), with mixed engagement industry engagement in the top 8% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Higgins experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Higgins performed 19,983 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Higgins receive payments from pharmaceutical companies?
Yes. Dr. Higgins received a total of $13,204 from 38 companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Higgins's costs compare to other ophthalmologists in Bloomfield?
Dr. Higgins's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Higgins) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Bloomfield
Browse ophthalmologists in Bloomfield ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in NJ
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in NJ
Which NJ ophthalmologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Roche TCRC, Inc. Payments to Doctors
See all physicians who received payments from Roche TCRC, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology